Sacramento State will officially become the 138th FBS program when it formally joins the MAC on July 1. During such ...

The new series of data not only revises the base year for calculation purposes to 2022-23, it also incorporates several vital changes with an aim to give a more accurate measurement of the size of the ...

And until price escapes the cage it has been pacing inside for months, the golden ticket has expired. There is a particular ...

However, increasingly, it does look like time is not on Russia’s side for specific reasons. The Russian military is still struggling to achieve even Moscow’s minimal political objectives, which is the ...

The FT put together a complex analysis of what the future of Detroit’s car companies will look like in 2050. It quoted Glenn Mercer, an independent automotive researcher saying, “Simple extrapolation ...

Recent incidents from AWS and Meta tell us what we should already know: autonomous agents ignore instructions when you least ...

Both boosters and sceptics have strongly held opinions on AI tools like ChatGPT, but after an experiment in vibe coding, I have realised that both camps are wrong, says Jacob Aron ...

As AI scaling limits emerge and exponential growth slows, leaders must rethink strategy, risk, and time horizons before today ...

Former Chief Statistician Pronab Sen discusses India’s new 2022-23 GDP base year series. While commending MoSPI's ...

AI rattled cybersecurity markets after Anthropic launched Claude Code Security. Here’s what actually changed, what didn’t and how leaders should respond.

If you are wondering whether Viking Therapeutics at around US$33.75 is still a sensible entry or hold after its run in the spotlight, you are not alone. The stock has moved 10.8% over the last 7 days, ...